Recent ME News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 09:05:59 PM
- 23andMe Regains Compliance With Nasdaq Listing Requirements • GlobeNewswire Inc. • 10/30/2024 09:00:00 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/29/2024 08:27:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 08:06:54 PM
- 23andMe Appoints Three New Independent Directors to Board • GlobeNewswire Inc. • 10/29/2024 11:30:00 AM
- 23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South • GlobeNewswire Inc. • 10/17/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 12:21:00 PM
- 23andMe Announces Completion of 1-for-20 Reverse Stock Split • GlobeNewswire Inc. • 10/16/2024 12:15:00 PM
- 23andMe Announces 1-for-20 Reverse Stock Split • GlobeNewswire Inc. • 10/11/2024 12:15:00 PM
- 23andMe Announces Mathew Knowles as New Brand Ambassador • GlobeNewswire Inc. • 10/08/2024 11:00:00 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/30/2024 08:58:24 PM
- 23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating • GlobeNewswire Inc. • 09/25/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 08:39:00 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/18/2024 12:10:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 12:05:52 PM
- Meta Strengthens Child Privacy on Instagram; Google Overturns $1.7 Billion Antitrust Fine; Snap Updates Spectacles • IH Market News • 09/18/2024 10:13:07 AM
- Independent Directors of 23andMe Resign from Board • GlobeNewswire Inc. • 09/17/2024 08:26:04 PM
- 23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial • GlobeNewswire Inc. • 09/15/2024 07:00:00 AM
- 23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study • GlobeNewswire Inc. • 09/15/2024 07:00:00 AM
- One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations • GlobeNewswire Inc. • 09/12/2024 08:05:00 PM
- Norfolk Southern CEO Fired, Ryanair Lowers Fare Forecast, 23andMe Considers Acquisition Proposals • IH Market News • 09/12/2024 10:02:29 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/11/2024 08:45:16 PM
- 23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024 • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 08:32:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 08:31:26 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM